Under new leadership, the United States Patent and Trademark Office has recently adjusted its approach to patentability of artificial intelligence technologies in multiple meaningful respects.
Continue Reading Recalibrating AI Patent Strategy: What the USPTO Shift Means — and What it Doesn’t
The Federal Circuit’s March decision in In re Xencor, Inc., No. 24-1870 (Fed. Cir. Mar. 13, 2025) has altered the landscape for patent applicants using a Jepson claim format, creating new challenges that may warrant careful consideration.
Continue Reading Federal Circuit’s Xencor Decision: Considerations for Jepson Claims and Implications for 35 U.S.C. § 101 Analysis
Patents are more than safeguards against competitors: They’re often attractive to investors and provide a competitive edge in saturated markets. In addition, they enable licensing opportunities and pave the way for an eventual exit.
Continue Reading How Startups Can Use a Patent Strategy as a Competitive Advantage
Many startups are pioneering technologies that are transforming the way we live, learn, and work. However, with great innovation comes great competition, and having a solid intellectual property (IP) strategy can make or break these companies, especially when these companies are in their early stages and IP may not be on top of mind. To
Quantum computing companies regularly file patent applications, but will the patents that result expire before they are commercially relevant, or could they skyrocket in value in a few years? As explained below, this is likely an excellent time to pursue patent protection for quantum technologies. Applicants should, however, present their technology carefully to get the
After building for some time, the excitement surrounding the potential of quantum computing has recently gained momentum. Quantum computing attracted $1.2 billion from venture capitalists in 2023 even as overall investment in technology dropped. Given that quantum computing has yet to perform a real-world use case, why is investment in this area so strong?
A
Patents buttress and backstop growth for medical technology (medtech) companies, period. This is especially so for early-stage ventures staking their claim in the medtech ecosystem. A strategic patent portfolio is an essential building block to have in place for a medtech company’s growth and success, especially when it comes to generating revenue or fundraising. And
David J. Dykeman, co-managing shareholder of global law firm Greenberg Traurig, LLP’s Boston office and co-chair of the firm’s global Life Sciences & Medical Technology Group, was featured on the Product Success Podcast: Quality and Medical Devices on Sept. 16 hosted by Chuck Serrin, vice president industry marketing, medical-tech and life sciences, and
From floating infrastructure to biohacking, floating solar farms to AgTech, projects that are first of their kind bring with them exciting opportunities, but also unique legal complexities. In this recent Environmental Law Institute webinar, Maneuvering “Unicorns” – Opportunities and Risks of Unprecedented Projects, GT Environmental Practice Shareholders Jillian C. Kirn and Kerri L. Barsh
